EXTON, Pa., May 26, 2011 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at the Jefferies 2011 Global Healthcare Conference at The Grand Hyatt in New York, on Tuesday, June 7, 2011.
Joseph W. Kaufmann, Kensey Nash's President and CEO, will deliver the Company's presentation, beginning at approximately 8:00 a.m. (ET). To hear the live webcast of the Kensey Nash presentation, go to http://wsw.com/webcast/jeff60/knsy/. The webcast will be archived for ninety days following the live presentation. The presentation materials will also be available on the company's website (www.kenseynash.com) beginning at 8:00 a.m. (ET) on Tuesday, June 7, 2011.
About Kensey Nash Corporation. Kensey Nash Corporation is a medical device company primarily focused on regenerative medicine utilizing its proprietary collagen and synthetic polymer technology. The Company is recognized as a leader for innovative product development and unique technology in the field of resorbable biomaterials. The Company has an extensive range of products, which are sold through strategic partners in multiple medical markets, including the cardiology, orthopaedic, sports medicine, spine, endovascular and general surgery markets. For more information, visit www.kenseynash.com.
SOURCE Kensey Nash Corporation
Advertisement
Joseph W. Kaufmann, Kensey Nash's President and CEO, will deliver the Company's presentation, beginning at approximately 8:00 a.m. (ET). To hear the live webcast of the Kensey Nash presentation, go to http://wsw.com/webcast/jeff60/knsy/. The webcast will be archived for ninety days following the live presentation. The presentation materials will also be available on the company's website (www.kenseynash.com) beginning at 8:00 a.m. (ET) on Tuesday, June 7, 2011.
Advertisement
About Kensey Nash Corporation. Kensey Nash Corporation is a medical device company primarily focused on regenerative medicine utilizing its proprietary collagen and synthetic polymer technology. The Company is recognized as a leader for innovative product development and unique technology in the field of resorbable biomaterials. The Company has an extensive range of products, which are sold through strategic partners in multiple medical markets, including the cardiology, orthopaedic, sports medicine, spine, endovascular and general surgery markets. For more information, visit www.kenseynash.com.
SOURCE Kensey Nash Corporation
